Routine clinical laboratory evaluation demonstrates limited utility of Fourier-transform infrared spectroscopy for subspecies identification of the Mycobacterium abscessus complex
Open Access
- 11 November 2026
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (11)
Abstract
The Mycobacterium abscessus complex (MABC) comprises three closely related subspecies whose accurate identification is clinically important because inducible macrolide resistance is largely determined by the functional status of erm(41) (1). However, reliable subspecies discrimination remains challenging in routine clinical microbiology.Keywords
Funding Information
- Japan Agency for Medical Research and Development (26fk0108714)
- Japan Agency for Medical Research and Development (JP26wm0125007, JP26wm0225054, JP26wm0325076)
- Japan Society for the Promotion of Science (JP23K07958, JP25K02850-B, JP64K13992)
- Japan Society for the Promotion of Science (JP24H00331, JP25K02690, JP25K02850-A)
- Japan Agency for Medical Research and Development (26fk0108750, 26wm0225054, 26wm0225063)
- Japan Agency for Medical Research and Development (JP26ak0101300, JP26fk0108701, JP26fk0534018, JP26gm1610003, JP26gm1610007)
This publication has 6 references indexed in Scilit:
- Lipid fingerprinting by MALDI Biotyper Sirius instrument fails to differentiate the three subspecies of the Mycobacterium abscessus complexJournal of Clinical Microbiology, 2025
- The IR Biotyper as a tool for typing organisms of significance for hospital epidemiology- A subject reviewDiagnostic Microbiology and Infectious Disease, 2024
- Application of FT-IR Spectroscopy for Mycobacterium abscessus complex subspecies differentiationJournal of Microbiological Methods, 2023
- Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine LearningJournal of Clinical Microbiology, 2023
- Global phylogenomic analyses of Mycobacterium abscessus provide context for non cystic fibrosis infections and the evolution of antibiotic resistanceNature Communications, 2021
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineClinical Infectious Diseases, 2020